Ashwin Somasundaram
Medical Oncology · Unc Physicians and Associates
Credentials: · · ·
History
- 2013
University of Texas Southwestern
Research
Therapeutic targeting of regulatory T cells in cancer
Review · Trends in cancer · 2022 · 219 citations
The Role of the Estrogen Pathway in the Tumor Microenvironment
Review · International Journal of Molecular Sciences · 2018 · 156 citations
Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity
Nature Immunology · 2020 · 136 citations
- AM
5 papers
5 papers
5 papers
5 papers
5 papers
- BM
4 papers
4 papers
- MS
4 papers
Grants
- 2023–2028
The Role of IL6-Induced LAG3 as a Resistance Mechanism to PD1 Blockade in NSCLC Patients
National Cancer Institute · K08
Contact PI · $1.1M · Univ of North Carolina Chapel Hill
Clinical trials
- 2025–2027
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
Principal investigator · Recruiting · Phase 1, Phase 2
UNC Lineberger Comprehensive Cancer Center
- 2024–2030
Autologous CAR-T Cells Targeting B7-H3 in PDAC
Principal investigator · Recruiting · Phase 1
UNC Lineberger Comprehensive Cancer Center
- 2019–2030
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
Principal investigator · Recruiting · Phase 2
UNC Lineberger Comprehensive Cancer Center
- 2019–2022
Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas
Principal investigator · Completed · Phase 2
Ashwin Somasundaram